Trial Profile
A confirmatory trial assessing the pharmacokinetics of buprenorphine/naloxone for the treatment of opioid dependence.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 22 Dec 2011 Status changed from recruiting to completed.
- 20 Dec 2011 Results reported in a BioDelivery Sciences media release.
- 15 Nov 2011 New trial record